Lupin Limited has informed the Exchange regarding a press release dated January 04, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and SaxagliptinTablets.".
Press Release Jan 04 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Dec 27 2023
- Press Release Dec 21 2023
- Press Release (Revised) Dec 15 2023
- Press Release Dec 15 2023
- Press Release Dec 14 2023
Later from Lupin
- Press Release Jan 08 2024
- Press Release Jan 09 2024
- Press Release Jan 10 2024
- Lupin Limited Press Release Jan 14 2024
- Press Release Jan 18 2024
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin